Science behind Geneveve
While using cryogen-cooled monopoly radiofrequency the Geneveve treatment begins to deliver gentle volumetric heating while cooling the surface tissue. This unique technology is the only treatment with algorithmically-controlled cooling. Substantial heating at depth is required to both tighten and strengthen the tissue and Geneveve’s cryogen-cooled monopoly radiofrequency (CMRF) technology delivers volumetric heating at precise temperatures to stimulate robust neocollagenesis.
Geneveve uses advanced technologies to ensure a comfortable and successful treatment experience. Its reverse thermal gradient cools and protects the surface mucosa while enabling significant heating of deep tissue, while it’s capacitive coupling distributes energy evenly across the treatment tip for uniform heating. Geneveve has a reproducible delivery with parameters and algorithms that are preset for controlled heating and cooling and its monopoly energy penetrates 3-5 mm deep into connective tissue.
Viveve undertook and successfully completed a multicenter, blinded, randomized, sham controlled study of an elective vaginal procedure to assess the effect the treatment had on women suffering from the changes their bodies undergo after vaginal childbirth. This study demonstrated that there were NO serious adverse events in patients treated with the active treatment. The study also showed that improvement of arousal and/or orgasm was statistically significant as self-reported by 9 out of 10 patients. Further, two previous pilot clinical trials conducted by Viveve in the U.S. and Japan, showed sustained tightening at 12 months.
This unique treatment is a comfortable, discreet, and single-session experience that is painless and can be done in approximately 30 minutes. Designed for improving women’s health and overall quality of life, Geneveve is a difference women can FEEL.
TO LEARN MORE ABOUT OUR GENEVEVE SERVICES, PLEASE CONTACT US (817) 473-2120 OR EMAIL APPOINTMENTS@MARKBISHARAMD.COM TO SCHEDULE AN APPOINTMENT.